Prostate biopsy and infectious complications

Prostate biopsy is the gold standard diagnosis of prostate cancer. In the last years various pivotal developments and changes have made urologists to re-think how to best perform prostate biopsies. Urologists face increasing rates of infectious complications due to raising antibiotic resistance, withdrawal of fluoroquinolones for prophylaxis due to side effects, and more men having risk factors in their practices.

The aims of this course are to encourage urologists to learn the current evidence on infectious complications and strategies how to avoid them. The webinar consists of two twenty-minute talks and a Q&A.

This session is organised by the European Section of Infections in Urology (ESIU) and the guidelines section on urological infections.

G. Bonkat, Basel (CH)
J.F. Alidjanov, Giessen (DE)
T. Cai, Trento (IT)

Publication date: March 2021
Available languages: English
Topic: Prostate biopsy and infectious complications
CME: 1 European CME credits (ECMEC)
Duration: approx. 60-90 minutes